ZA97741B - Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders. - Google Patents

Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.

Info

Publication number
ZA97741B
ZA97741B ZA9700741A ZA97741A ZA97741B ZA 97741 B ZA97741 B ZA 97741B ZA 9700741 A ZA9700741 A ZA 9700741A ZA 97741 A ZA97741 A ZA 97741A ZA 97741 B ZA97741 B ZA 97741B
Authority
ZA
South Africa
Prior art keywords
treatment
combined preparation
gynaecological disorders
pharmaceutical combined
pharmaceutical
Prior art date
Application number
ZA9700741A
Other languages
English (en)
Inventor
Klaus Stoeckemann
Peter Muhn
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA97741B publication Critical patent/ZA97741B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9700741A 1996-01-29 1997-01-29 Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders. ZA97741B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19604231A DE19604231A1 (de) 1996-01-29 1996-01-29 Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen

Publications (1)

Publication Number Publication Date
ZA97741B true ZA97741B (en) 1997-07-30

Family

ID=7784640

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9700741A ZA97741B (en) 1996-01-29 1997-01-29 Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.

Country Status (20)

Country Link
US (3) US7309691B2 (no)
EP (1) EP0877621A1 (no)
JP (1) JP2000505422A (no)
KR (1) KR19990082080A (no)
CN (1) CN1209750A (no)
BG (1) BG63248B1 (no)
BR (1) BR9707210A (no)
CZ (1) CZ239198A3 (no)
DE (1) DE19604231A1 (no)
EA (1) EA001178B1 (no)
HU (1) HUP9901288A3 (no)
IL (1) IL125557A0 (no)
MX (1) MX9806082A (no)
NO (1) NO983465L (no)
PL (1) PL328066A1 (no)
SK (1) SK98798A3 (no)
TR (1) TR199801452T2 (no)
TW (1) TW577735B (no)
WO (1) WO1997027863A1 (no)
ZA (1) ZA97741B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US6096764A (en) * 1997-08-21 2000-08-01 Eli Lilly And Company Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration
EP1082129B1 (en) 1998-04-23 2003-10-29 Zentaris AG Method for the treatment of fertility disorders
US8193252B1 (en) 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
KR100864547B1 (ko) * 1999-08-31 2008-10-20 바이엘 쉐링 파마 악티엔게젤샤프트 양성 호르몬 의존성 부인과 질병의 치료 및 예방을 위한메조프로게스틴 (프로게스테론 수용체 조절물질)
UA73956C2 (en) * 1999-09-23 2005-10-17 Zentaris Gmbh Method for therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction due to extrauterine proliferation of endometrial tissue
US7005418B1 (en) 1999-09-23 2006-02-28 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
US20030176360A1 (en) * 2000-07-05 2003-09-18 Yasutaka Igari Medicinal preparations for treating sex hormone-dependent diseases
DE10050831A1 (de) 2000-10-05 2002-05-02 Veyx Pharma Gmbh Verfahren zum Zyklusstart bei weiblichen Zuchttieren
IL145838A (en) * 2000-10-16 2008-11-03 Pfizer Prod Inc Use of an estrogen agonist / antagonist to produce a drug for the treatment of vaginitis
AU2002235348A1 (en) * 2001-01-17 2002-07-30 Praecis Pharmaceuticals Inc. Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators
US20050215528A1 (en) * 2001-08-10 2005-09-29 Shuichi Furuya Gnrh agonist combination drugs
WO2006098371A1 (ja) * 2005-03-16 2006-09-21 Masao Igarashi 子宮内膜症および子宮腺筋症の治療剤および予防剤
EP2266568A1 (en) 2009-05-26 2010-12-29 Æterna Zentaris GmbH Use of LHRH antagonists in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders
EP2266567A1 (en) 2009-05-26 2010-12-29 Æterna Zentaris GmbH Use of cetrorelix in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders
KR101731008B1 (ko) * 2010-06-16 2017-04-27 앙도르쉐르슈 인코포레이티드 에스트로겐-관련 질병의 치료 또는 예방 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5457116A (en) * 1993-10-15 1995-10-10 Eli Lilly And Company Methods of inhibiting uterine fibrosis
US5451590A (en) * 1993-12-21 1995-09-19 Eli Lilly & Co. Methods of inhibiting sexual precocity
US5593987A (en) * 1993-12-21 1997-01-14 Eli Lilly And Company Methods of inhibiting breast disorders
US5451589A (en) * 1993-12-21 1995-09-19 Eli Lilly And Company Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
US5455275A (en) * 1994-05-11 1995-10-03 Eli Lilly And Company Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
US6096764A (en) 1997-08-21 2000-08-01 Eli Lilly And Company Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration

Also Published As

Publication number Publication date
BG63248B1 (bg) 2001-07-31
IL125557A0 (en) 1999-03-12
US7309691B2 (en) 2007-12-18
TW577735B (en) 2004-03-01
BG102660A (en) 1999-06-30
TR199801452T2 (xx) 1998-10-21
EA001178B1 (ru) 2000-10-30
BR9707210A (pt) 1999-04-06
MX9806082A (es) 1998-10-31
US20020198155A1 (en) 2002-12-26
CZ239198A3 (cs) 1998-11-11
US20010041672A1 (en) 2001-11-15
CN1209750A (zh) 1999-03-03
HUP9901288A2 (hu) 1999-08-30
EP0877621A1 (de) 1998-11-18
PL328066A1 (en) 1999-01-04
NO983465D0 (no) 1998-07-28
KR19990082080A (ko) 1999-11-15
DE19604231A1 (de) 1997-07-31
SK98798A3 (en) 1999-03-12
HUP9901288A3 (en) 2000-03-28
JP2000505422A (ja) 2000-05-09
EA199800666A1 (ru) 1999-02-25
WO1997027863A1 (de) 1997-08-07
US20020032156A1 (en) 2002-03-14
NO983465L (no) 1998-09-18

Similar Documents

Publication Publication Date Title
HUP0100069A3 (en) 4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders
HUP9903613A3 (en) Improvement in the taste of active pharmaceutical ingredients
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
NZ314903A (en) A peg-ifn alpha conjugate and its use in the treatment of immunomodulatory disorders
HUP0004439A3 (en) 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
EP0924983A4 (en) S (-) - TOLTERODINE FOR THE TREATMENT OF URINARY AND GASTROINTESTINAL DISORDERS
ZA9710339B (en) Xanthines and their therapeutic use
ZA200204493B (en) Pharmaceutical combinations and their use in treating gastrointestinal disorders.
SI0825178T1 (en) Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or in diagnostic agents and drugs containing them
ZA97741B (en) Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.
IL153236A0 (en) The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
ZA975288B (en) The use of TCET in the prophylaxis and treatment of allergies.
GB9419553D0 (en) Polypeptides and their use in the treatment of auto-immune disease
IL129460A0 (en) Use of lofexidine in the treatment of behavioral disorders
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
HUP9902802A3 (en) Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
IL127350A0 (en) Combinations comprising VX478 zidovudine and/or 1592U89 for use in the treatment of HIV
ZA976547B (en) Lipid-binding proteins and their therapeutic and diagnostic use
AU3061199A (en) Skin treatment compositions and the use thereof
ZA9610264B (en) Preparation for use in the treatment of skin disorders.
WO1994006345A3 (en) Immunosorbent for use in the diagnosis of neuro-psychological disorders, and use thereof
ZA9810815B (en) Use of lectin preparations in the treatment of bladder carcinoma
GB9616504D0 (en) Therapeutic product and its use
IL127040A0 (en) Use of substituted azaspirane in the treatment of asthma
ZA991021B (en) Benzofuran-4-carboxamides and their therapeutic use.